Walls ML, et al. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes. Hum Reprod. 2015;30(1):88–96.
Article CAS PubMed Google Scholar
Yang H, et al. Factors Influencing the In Vitro Maturation (IVM) of Human Oocyte. Biomedicines. 2021;9(12):1904.
Article CAS PubMed PubMed Central Google Scholar
Reichman DE, et al. Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles. Fertil Steril. 2014;102(1):99–102.
Article CAS PubMed Google Scholar
Wu YG, et al. Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval. J Endocrinol. 2015;226(3):167–80.
Article CAS PubMed Google Scholar
Gan R, et al. Time interval between hCG administration and oocyte retrieval and ART outcomes: an updated systematic review and meta-analysis. Reprod Biol Endocrinol. 2023;21(1):61.
Article CAS PubMed PubMed Central Google Scholar
Findeklee S, Hachenberg J, Kienast K. In vitro maturation of oocytes with consecutive clinical pregnancy after accidental premature ovulation induction-a rescue strategy in art. Acta Endocrinol (Buchar). 2021;17(1):106–10.
Article CAS PubMed Google Scholar
Lu X, et al. Decrease in preovulatory serum estradiol is a valuable marker for predicting premature ovulation in natural/unstimulated in vitro fertilization cycle. J Ovarian Res. 2018;11(1):96.
Article CAS PubMed PubMed Central Google Scholar
Pelinck MJ, et al. Efficacy of natural cycle IVF: a review of the literature. Hum Reprod Update. 2002;8(2):129–39.
Article CAS PubMed Google Scholar
Trounson A, Wood C, Kausche A. In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril. 1994;62(2):353–62.
Article CAS PubMed Google Scholar
Yang ZY, Chian RC. Development of in vitro maturation techniques for clinical applications. Fertil Steril. 2017;108(4):577–84.
Gilchrist RB, Smitz J. Oocyte in vitro maturation: physiological basis and application to clinical practice. Fertil Steril. 2023;119(4):524–39.
Braam SC, et al. The perspective of women with an increased risk of OHSS regarding the safety and burden of IVF: a discrete choice experiment. Hum Reprod Open. 2020;2020(2):hoz034.
Article CAS PubMed PubMed Central Google Scholar
Child TJ, et al. A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries. Obstet Gynecol. 2002;100(4):665–70.
Gremeau AS, et al. In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles. Fertil Steril. 2012;98(2):355–60.
Walls ML, et al. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes. Hum Reprod. 2014;30(1):88–96.
Kuang Y, et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015;104(1):62-70.e3.
Article CAS PubMed Google Scholar
Xu H, et al. GnRH antagonist protocol with cessation of cetrorelix on trigger day improves embryological outcomes for patients with sufficient ovarian reserve. Front Endocrinol (Lausanne). 2021;12:758896.
Zhang D, et al. Flexible low-dose GnRH antagonist protocol is effective in patients with sufficient ovarian reserve in IVF. Front Endocrinol (Lausanne). 2018;9:767.
De Vos M, et al. Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome. Fertil Steril. 2011;96(4):860–4.
Shapiro BS, et al. Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day 5 or day 6 blastocysts may reflect differences in embryo-endometrium synchrony. Fertil Steril. 2008;89(1):20–6.
Shapiro BS, et al. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. Fertil Steril. 2011;96(2):344–8.
Uzelac PS, et al. Live birth following in vitro maturation of oocytes retrieved from extracorporeal ovarian tissue aspiration and embryo cryopreservation for 5 years. Fertil Steril. 2015;104(5):1258–60.
Mohsenzadeh M, et al. Embryo cryopreservation following in-vitro maturation for fertility preservation in a woman with Mullerian adenosarcoma: a case report. J Hum Reprod Sci. 2017;10(2):138–41.
Article PubMed PubMed Central Google Scholar
Qiong Z, et al. Clinical validation of pinopode as a marker of endometrial receptivity: a randomized controlled trial. Fertil Steril. 2017;108(3):513-517.e2.
Bourgain C, Devroey P. The endometrium in stimulated cycles for IVF. Hum Reprod Update. 2003;9(6):515–22.
Ubaldi F, et al. Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril. 1997;67(3):521–6.
Article CAS PubMed Google Scholar
de Ziegler D. Hormonal control of endometrial receptivity. Hum Reprod. 1995;10(1):4–7.
Develioglu OH, et al. Endometrial estrogen and progesterone receptor and pinopode expression in stimulated cycles of oocyte donors. Fertil Steril. 1999;71(6):1040–7.
Article CAS PubMed Google Scholar
Hofmann GE, et al. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril. 1993;60(4):675–9.
Article CAS PubMed Google Scholar
Chetkowski RJ, Kiltz RJ, Salyer WR. In premature luteinization, progesterone induces secretory transformation of the endometrium without impairment of embryo viability. Fertil Steril. 1997;68(2):292–7.
Article CAS PubMed Google Scholar
Franasiak JM, et al. Both slowly developing embryos and a variable pace of luteal endometrial progression may conspire to prevent normal birth in spite of a capable embryo. Fertil Steril. 2016;105(4):861–6.
Mesen TB, Young SL. Progesterone and the luteal phase: a requisite to reproduction. Obstet Gynecol Clin North Am. 2015;42(1):135–51.
Article PubMed PubMed Central Google Scholar
Evans J, Salamonsen LA. Too much of a good thing? Experimental evidence suggests prolonged exposure to hCG is detrimental to endometrial receptivity. Hum Reprod. 2013;28(6):1610–9.
Comments (0)